| Recruiting | SPI-1005 for the Treatment of Meniere's Disease (Open Label) NCT06859788 | Sound Pharmaceuticals, Incorporated | Phase 3 |
| Recruiting | Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes NCT07518069 | IRCCS San Raffaele | — |
| Not Yet Recruiting | Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease NCT06765993 | Lunan Better Pharmaceutical Co., LTD. | Phase 2 / Phase 3 |
| Recruiting | Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation NCT06001593 | Seoul National University Hospital | Phase 1 / Phase 2 |
| Suspended | Deep Phenotyping of Hearing Instability Disorders: Cohort Establishment, Biomarker Identification, Development NCT04806282 | National Institute on Deafness and Other Communication Disorders (NIDCD) | — |
| Suspended | CAVA: Dizziness Trial NCT04026516 | Julie Dawson | N/A |
| Recruiting | Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inne NCT03587701 | Northwell Health | Phase 2 |
| Completed | SPI-1005 for the Treatment of Patients With Meniere's Disease NCT03325790 | Sound Pharmaceuticals, Incorporated | Phase 2 |
| Terminated | A 6-Month Extension Study of OTO-104 in Meniere's Disease NCT02768662 | Otonomy, Inc. | Phase 3 |
| Terminated | Open Label Study of OTO-104 in Subjects With Meniere's Disease NCT02740387 | Otonomy, Inc. | Phase 2 |
| Terminated | Study of OTO-104 in Subjects With Unilateral Meniere's Disease NCT02717442 | Otonomy, Inc. | Phase 3 |
| Terminated | Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease NCT02530931 | University Hospital, Grenoble | Phase 4 |
| Terminated | A 6-Month Extension Study of OTO-104 in Meniere's Disease NCT02706730 | Otonomy, Inc. | Phase 3 |
| Completed | Study to Evaluate SPI-1005 in Adults With Meniere's Disease NCT02603081 | Sound Pharmaceuticals, Incorporated | Phase 1 / Phase 2 |
| Completed | Study of OTO-104 in Subjects With Unilateral Meniere's Disease NCT02612337 | Otonomy, Inc. | Phase 3 |
| Completed | Cochlear Implantation After Labyrinthectomy or a Translabyrinthine Surgical Approach NCT02309099 | University of North Carolina, Chapel Hill | N/A |
| Completed | A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom NCT02265393 | Otonomy, Inc. | Phase 2 |
| Completed | Study of Lamotrigine to Treat Ménière's Disease NCT02158585 | Dent Neuroscience Research Center | Phase 2 |
| Completed | OTO-104 for the Treatment of Meniere's Disease NCT01412177 | Otonomy, Inc. | Phase 2 |
| Completed | Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets NCT02718846 | Alvogen Korea | Phase 4 |
| Completed | Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent NCT02080312 | University of California, San Diego | N/A |
| Terminated | Famvir for Treatment of Hearing in Unilateral Meniere's Disease NCT01526408 | House Research Institute | Phase 3 |
| Unknown | Efficacy of Antiviral Medications in Controlling Vertigo Attacks of Patients With Meniere's Disease NCT01729767 | Tehran University of Medical Sciences | Phase 2 / Phase 3 |
| Completed | Clinical Trial of Traditional Chinese Diaoshi Jifa Therapy of Meniere's Disease NCT01454726 | Beijing Administration of Traditional Chinese Medicine Bureau | Phase 3 |
| Completed | OTO-104 for Meniere's Disease NCT01084525 | Otonomy, Inc. | Phase 1 |
| Completed | Transtympanic Gentamicin vs. Steroids in Refractory Meniere's Disease NCT00802529 | Imperial College London | Phase 2 / Phase 3 |
| Unknown | Stress Management Therapy for Meniere's Disease NCT01099046 | Osaka University | N/A |
| Completed | Efficacy of Local Overpressure Treatment for Meniere's Disease NCT00831688 | Klinikum der Universitaet Muenchen, Grosshadern | Phase 4 |
| Completed | Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Havi NCT00160238 | Solvay Pharmaceuticals | Phase 4 |
| Completed | Sildenafil For Meniere's Disease NCT00145483 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 |
| Completed | Effects of Endolymphatic Sac Drainage With Steroids for Meniere's Disease NCT00500474 | Osaka University | N/A |